A Study of GSK573719 in Healthy Japanese Male Subjects
NCT01013974
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
GSK573719 250 μg
DRUG:
GSK573719 500 μg
DRUG:
GSK573719 1000 μg
DRUG:
GSK573719 matching Placebo
Sponsor
GlaxoSmithKline